
Tuberculosis - World Health Organization (WHO)
Oct 29, 2024 · Tuberculosis (TB) is an infectious disease caused by bacteria that most often affects the lungs. It spreads through the air when people with TB cough, sneeze or spit. …
Tuberculosis - World Health Organization (WHO)
Mar 5, 2025 · Tuberculosis (TB) is the world’s top infectious killer. Nearly 4500 people lose their lives and 30 000 people fall ill with TB each day. TB is contagious and airborne. It is caused by …
Tuberculosis - World Health Organization (WHO)
Jan 18, 2018 · Tuberculosis (TB) is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs. Tuberculosis is curable and preventable. TB is spread from person to …
WHO TB guidelines: recent updates - World Health Organization …
The communication includes new information about treatment decision algorithms, the use of Xpert MTB/RIF Ultra to diagnose pulmonary TB using gastric aspirate and stool specimens, a …
Tuberculosis in China - World Health Organization (WHO)
Tuberculosis (TB) is the world’s top infectious killer. It is a contagious, airborne disease caused by bacteria (Mycobacterium tuberculosis) that most commonly affects the lungs. When people …
1.4 National TB prevalence surveys - World Health Organization …
a The P:N ratio is for smear-positive pulmonary TB, except for Bangladesh, the Democratic People's Republic of Korea, Kenya, Myanmar (2018), Namibia (2018), Uganda, Viet Nam …
Global tuberculosis report 2024 - World Health Organization (WHO)
Oct 29, 2024 · The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of …
Tuberculosis: Systematic screening - World Health Organization …
May 23, 2024 · Tuberculosis preventive treatment (TPT) consists of a course of one or more anti-tuberculosis medicines given with the intent of preventing the development of TB disease. TPT …
Tuberculosis: Multidrug-resistant (MDR-TB) or rifampicin-resistant …
May 20, 2024 · Longer individualized regimens: for patients with MDR/RR-TB who are not eligible for, or had no favorable treatment outcome using, the above 6-month or 9-month regimens, …
Algorithm for laboratory diagnosis and treatment-monitoring of ...
Oct 1, 2017 · The document presents comprehensive algorithms for diagnosis and treatment-monitoring of pulmonary TB and MDR-TB using rapid molecular techniques recommended by …
- Some results have been removed